Clinical Trials Logo

Filter by:
NCT ID: NCT05406466 Recruiting - Melanoma Clinical Trials

Cryoablation Combined With Tislelizumab Plus Lenvatinib in Patients With Melanoma Liver Metastasis

Start date: July 15, 2022
Phase: Phase 2
Study type: Interventional

The objective of this study is to evaluate the efficacy and safety of cryoablation combined with Tislelizumab plus lenvatinib in patients with melanoma liver metastasis.

NCT ID: NCT05406427 Recruiting - ARDS Clinical Trials

Monitorings the Physiological Mechanism of Airway Pressure Release Ventilation in ARDS Patients by EIT

Start date: March 1, 2022
Phase:
Study type: Observational

Effects of airway pressure release ventilation on pulmonary ventilation, shunt and perfusion in patients with ARDS

NCT ID: NCT05406206 Recruiting - Clinical trials for Liver Metastasis Colon Cancer

Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapy

Start date: February 25, 2022
Phase: Phase 2
Study type: Interventional

Fruquintinib (HMPL-013) is a novel oral small molecule that selectively inhibits vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3 and has demonstrated potent inhibitory effects on multiple human tumor xenografts. Combined with hepatic arterial infusion chemotherapy (HAIC), this study is conducted to assess the efficacy and safety of this regimen in patients with unresectable colorectal cancer liver metastases as the third-line therapy.

NCT ID: NCT05406154 Recruiting - Clinical trials for Mantle Cell Lymphoma (MCL)

Ibrutinib Combined With Bendamustine and Rituximab in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged > 65 Years

Start date: December 30, 2020
Phase:
Study type: Observational

This study is a prospective observational clinical trial. A total of 19 research centers were involved in this study. Each site plans to enroll 2-3 patients, and a total of 60 patients will be enrolled. Patients who met the diagnosis of mantle cell lymphoma by histological examination, ECOG (Eastern Oncology Collaborative Group) score 0-2, age >65 years, expected survival of more than 3 months, and at least one measurable lesion were included in this observational clinical trial. In this study, clinical data of patients treated with R-B regimen combined with ibrutinib will be collected, including routine clinical laboratory tests, examinations, and molecular biological data, for efficacy assessment and survival analysis. The main evaluation indicators are the total effective rate of 2 and 6 cycles of alternating R-CHOP/R-DHAP combined with ibrutinib in the treatment of newly treated muff cell lymphoma patients. The 3-year progression-free survival (PFS) and overall survival (OS) of the patients will be assessed, and adverse events to treatment will be collected to evaluate the safety of ibrutinib in combination with untreated mask cell lymphoma.

NCT ID: NCT05406141 Recruiting - Cow Milk Allergy Clinical Trials

Nutrition Sufficiency, Allergy Efficacy and Safety of Neocate Jr in Children With Food Protein Allergy

Start date: March 30, 2022
Phase: N/A
Study type: Interventional

The main purpose of this study is to evaluate efficacy and safety of an amino acid-based formula Neocate Jr in children with food protein allergy, and to evaluate nutrition sufficiency of Neocate Jr in 1 to 10 years old children with food protein allergy.

NCT ID: NCT05405621 Recruiting - Clinical trials for Locally Advanced/Metastatic Solid Tumours

Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009

Start date: August 2, 2022
Phase: Phase 1
Study type: Interventional

Primary objectives: - To evaluate the safety and tolerability of BAT8009 in patients with advanced solid tumours. - To determine the maximum tolerated dose (MTD) and recommended dose for Phase 2 (RP2D).

NCT ID: NCT05405530 Recruiting - Gastric Cancer Clinical Trials

Nasal Mask Kit in Gastrointestinal Endoscopy

NASO
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Hypoxia is the most common adverse event in gastrointestinal endoscopes sedated with propofol. The nasal mask oxygen kit has good sealing to ensure an adequate oxygen supply and is convenient and economical.The aim of this randomized study was to determine whether the nasal mask oxygen kit reduces the incidence of hypoxia in gastrointestinal endoscopes procedures.

NCT ID: NCT05404906 Recruiting - Clinical trials for Acute Myeloid Leukemia (AML) in Remission

AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission

Start date: June 25, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

This phase III trial is conducted to evaluate if azacitidine in combination with venetoclax as maintenance therapy improves relapse-free survival (RFS) for younger adults with favorable-risk acute myeloid leukemia (AML) who remained in first complete remission (CR1) following intensive consolidation.

NCT ID: NCT05404568 Recruiting - Clinical trials for Rehabilitation;Arthroplasty, Replacement, Knee

The Hierarchical Rehabilitation After Total Knee Arthroplasty

Start date: May 1, 2022
Phase:
Study type: Observational

Knee osteoarthritis (KOA) is one of the diseases that seriously affect the quality of human life, resulting in a significant disease burden. Total knee arthroplasty (TKA) is one of the ultimate treatments for knee osteoarthritis. Functional recovery after total knee arthroplasty depends on rehabilitation. With the incidence rate of knee osteoarthritis increasing, the amount of knee replacement surgery is increasing rapidly, the demand for medical resources and medical expenditure has increased. At present, there are many rehabilitation pathways after total knee arthroplasty, but there is no unified evidence-based medicine guide to guide postoperative rehabilitation. The current early rehabilitation pathways after total knee arthroplasty in China can be generally divided into three categories: inpatient rehabilitation, outpatient rehabilitation and home-based self-rehabilitation. The intensity and expenditure of rehabilitation treatment decrease in turn. Individual differences among patients lead to different rehabilitation treatment needs for functional recovery. How to predict the rehabilitation needs of patients after total knee arthroplasty and choose an appropriate rehabilitation pathway based on themselves need to be solved. We expected to establish a prediction model that we will be able to inform patients with knee osteoarthritis who just taken total knee arthroplasty and want to choose a pathway to rehabilitation by using the baseline status, that will help them to choose their best pathway to rehabilitation -- provide rehabilitation according to needs, save costs and improve the quality of life.

NCT ID: NCT05404555 Recruiting - Clinical trials for Acute Myocardial Infarction

Prognostic Value of Right Ventricular Myocardial Strain in Patients With Acute Myocardial Infarction

Start date: October 1, 2021
Phase:
Study type: Observational

For a long time, the right ventricle has been the "forgotten chamber", but with the deepening of people's understanding of the disease, right ventricular dysfunction has become an important factor to evaluate the disease progression and late prognosis of patients with AMI. Right ventricular myocardial strain derived from two-dimensional speckle tracking echocardiography is a new method for early evaluation of regional and global right ventricular systolic function, and its repeatability is much higher than that of LVEF. Acute inferior myocardial infarction is often caused by occlusion of the proximal middle segment of the right coronary artery. Many studies have confirmed that RVMS is an independent predictor of poor prognosis in patients with AIMI. However, 60% of the right ventricular systolic function is contributed by the left ventricle and interventricular septum, and the left anterior descending branch and the left circumflex branch are the main sources of blood supply to the left ventricle and interventricular septum, so in theory, non-RCA occlusion can also lead to varying degrees of right ventricular dysfunction. However, there are few studies on the role of RVMS in predicting the prognosis of AMI patients caused by non-RCA occlusion. Therefore, the purpose of this study is to prospectively study the value of dynamic changes of RVMS in predicting the prognosis of patients with acute myocardial infarction with different infarct-related vessels, in order to provide more clinical reference information for the diagnosis and treatment of AMI.